BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,584,212 | +82843.0% | 41,977 | +0.1% | 0.03% | -17.9% |
| Q2 2023 | $1,910 | +11.6% | 41,926 | -0.7% | 0.04% | +5.4% |
| Q1 2023 | $1,712 | -23.2% | 42,208 | -3.5% | 0.04% | -26.0% |
| Q4 2022 | $2,230 | -99.9% | 43,748 | +8.4% | 0.05% | -7.4% |
| Q3 2022 | $2,174,000 | -17.7% | 40,359 | -1.8% | 0.05% | -12.9% |
| Q2 2022 | $2,640,000 | -18.1% | 41,095 | -1.2% | 0.06% | -7.5% |
| Q1 2022 | $3,225,000 | -56.7% | 41,596 | -52.0% | 0.07% | -56.2% |
| Q4 2021 | $7,440,000 | +2.2% | 86,669 | -4.2% | 0.15% | -1.9% |
| Q3 2021 | $7,279,000 | +1.0% | 90,501 | +1.0% | 0.16% | -0.6% |
| Q2 2021 | $7,210,000 | -4.8% | 89,561 | -0.2% | 0.16% | -10.8% |
| Q1 2021 | $7,572,000 | +9.7% | 89,777 | +4.3% | 0.18% | +1.7% |
| Q4 2020 | $6,903,000 | +2.2% | 86,035 | +2.4% | 0.17% | -12.6% |
| Q3 2020 | $6,754,000 | -5.8% | 83,982 | +0.9% | 0.20% | -13.5% |
| Q2 2020 | $7,169,000 | -13.3% | 83,266 | -18.3% | 0.23% | -37.4% |
| Q1 2020 | $8,270,000 | -2.1% | 101,857 | +0.8% | 0.37% | +21.6% |
| Q4 2019 | $8,451,000 | -5.1% | 101,066 | -0.7% | 0.30% | -14.0% |
| Q3 2019 | $8,906,000 | -0.8% | 101,813 | -7.1% | 0.35% | -4.1% |
| Q2 2019 | $8,974,000 | -9.8% | 109,573 | -10.5% | 0.36% | -13.7% |
| Q1 2019 | $9,952,000 | +27.6% | 122,398 | +3.3% | 0.42% | +10.2% |
| Q4 2018 | $7,797,000 | -14.0% | 118,466 | +0.7% | 0.38% | -3.3% |
| Q3 2018 | $9,068,000 | +2.9% | 117,625 | -1.4% | 0.40% | -2.5% |
| Q2 2018 | $8,811,000 | +12.5% | 119,326 | -0.9% | 0.41% | +9.1% |
| Q1 2018 | $7,833,000 | +1.7% | 120,440 | +1.1% | 0.37% | +5.7% |
| Q4 2017 | $7,700,000 | +11.1% | 119,115 | +7.9% | 0.35% | +4.7% |
| Q3 2017 | $6,928,000 | -15.2% | 110,403 | -18.2% | 0.34% | -17.0% |
| Q2 2017 | $8,172,000 | +16.6% | 134,982 | -0.1% | 0.41% | +13.4% |
| Q1 2017 | $7,008,000 | +16.1% | 135,135 | -0.7% | 0.36% | +11.2% |
| Q4 2016 | $6,034,000 | +0.3% | 136,079 | +2.3% | 0.32% | -10.3% |
| Q2 2016 | $6,013,000 | +9.6% | 132,970 | -0.4% | 0.36% | +5.6% |
| Q1 2016 | $5,486,000 | +7.1% | 133,554 | -0.5% | 0.34% | +3.0% |
| Q4 2015 | $5,123,000 | +14.9% | 134,291 | -1.1% | 0.33% | +7.5% |
| Q3 2015 | $4,459,000 | -51.2% | 135,723 | +4.0% | 0.31% | -47.2% |
| Q2 2015 | $9,128,000 | -13.9% | 130,531 | -15.6% | 0.58% | -11.8% |
| Q1 2015 | $10,600,000 | -1.6% | 154,749 | +5.3% | 0.66% | -3.4% |
| Q4 2014 | $10,769,000 | +10.8% | 146,935 | +8.5% | 0.68% | 0.0% |
| Q3 2014 | $9,717,000 | +4.7% | 135,396 | +5.5% | 0.68% | +5.6% |
| Q2 2014 | $9,279,000 | +2.5% | 128,335 | +4.3% | 0.65% | -0.9% |
| Q1 2014 | $9,050,000 | +26.1% | 122,999 | +19.2% | 0.65% | +21.2% |
| Q4 2013 | $7,175,000 | +139.7% | 103,158 | +126.4% | 0.54% | +117.8% |
| Q3 2013 | $2,993,000 | -6.2% | 45,564 | -1.1% | 0.25% | -6.8% |
| Q2 2013 | $3,191,000 | – | 46,069 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |